Document Detail


Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes.
MedLine Citation:
PMID:  20099282     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diabetes is now generally accepted as a crucial event in the process of pancreatic cancer (PaC). However, molecular mechanisms underlying the relationship between diabetes and PaC are not fully understood. Regenerating gene (REG) Ialpha is a growth factor affecting pancreatic islet beta cells, and it has been shown to be involved in the carcinogenesis in gastrointestinal tract. It is rational to speculate that REG Ialpha plays a potential role in the pathogenesis of PaC with diabetes. The aim of this study was to evaluate the REG Ialpha protein expression profile in PaC with and without diabetes, and define the contribution of REG Ialpha on PaC development. We found that REG Ialpha protein preferentially expressed in cancerous tissues of PaC patients with diabetes by Western blot. REG Ialpha positive cancer cells in PaC with diabetes (n = 38) was significantly higher than that in subjects without diabetes (n = 42, p < 0.05) by immunohistochemical analysis. Furthermore, we found that overexpression of REG Ialpha protein in PaC cell lines resulted in accelerated cell proliferation and consequently tumor growth, both in vitro and in vivo. The findings suggest that REG Ialpha may act as one of the tumor promoter and contribute to the aggressive nature of PaC, especially in the subpopulation with diabetes. This study would shed new insights for understanding the molecular mechanisms underlying the link between diabetes and PaC.
Authors:
Lin Zhou; Ruifeng Zhang; Lishun Wang; Shaoming Shen; Hiroshi Okamoto; Akira Sugawara; Li Xia; Xiaoling Wang; Naoya Noguchi; Takeo Yoshikawa; Akira Uruno; Weiyan Yao; Yaozong Yuan
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  127     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-08-30     Completed Date:  2010-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1795-803     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Animals
Blotting, Western
Cell Proliferation
Colony-Forming Units Assay
Culture Media, Conditioned / pharmacology
Diabetes Mellitus, Type 2 / metabolism*,  pathology
Female
Humans
Immunoenzyme Techniques
Lithostathine / metabolism*
Male
Mice
Mice, Inbred BALB C
Middle Aged
Pancreatic Neoplasms / metabolism*,  pathology
Tumor Cells, Cultured
Up-Regulation
Chemical
Reg. No./Substance:
0/Culture Media, Conditioned; 0/Lithostathine; 0/REG1A protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population.
Next Document:  Sugar-Decorated Sugar Vesicles: Lectin-Carbohydrate Recognition at the Surface of Cyclodextrin Vesic...